2m 2m 2m 2m 2m 2m 2m
IMMUNOVANT (IMVT)
NASDAQ
$29.44+$1.05 (+3.72%)
Price as of Oct 22, 2026 7:30 PM EDT- $5.9BMarket Cap
- 50.16%1-Year Change
- BiotechnologyIndustry
IMMUNOVANT (IMVT)
$29.44+$1.05 (+3.72%)
IMVT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $28.38 | ||
Change | -$0.21 (-0.73%) | ||
Open | $28.97 | ||
High | $29.18 | ||
Low | $28.05 | ||
Previous Close | $28.59 | ||
Volume | 1,494,642 | ||
30-Day Average Volume | 1,621,831 | ||
1-Week Change | 1.72% | ||
1-Month Change | -23.67% | ||
1-Year Change | 50.16% | ||
3-Year Change | -19.05% | ||
5-Year Change | 235.06% | ||
Fundamentals | |||
Shares Outstanding | 206.6M | ||
Total Assets | $852.5M | ||
Market Cap | $5.9B | ||
Enterprise Value | $5.1B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$153.2M | ||
Free Cash Flow | -$124.4M | ||
EBIT | -$153.2M | ||
EBITDA | -$153.1M | ||
Net Working Capital | $734.1M | ||
EPS | -$0.75 | ||
Enterprise Value/EBITDA | -33 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 8 | ||
P/E | -38 | ||
PEG | 11 | ||
Price/Free Cash Flow | -47 | ||
Price/Operating Cash Flow | -47 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue